title: [Cannabis medicines in Norway--the basis for approval].
authors: Avdeling for legemiddelutredning, Statens legemiddelverk, Norway. lars.gramstad@noma.no
authors: Lars
authors: L
authors: Gramstad
authors: Anne S Onsgård
authors: AS
authors: Sagabråten
mesh_terms: D002185:Cannabidiol / Q000008:administration & dosage / Q000494:pharmacology / Q000592:standards*; D013759:Dronabinol / Q000008:administration & dosage / Q000494:pharmacology / Q000592:standards*; D017277:Drug Approval; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy; D009128:Muscle Spasticity / Q000188:drug therapy / Q000209:etiology; D009664:Norway; D058993:Oral Sprays; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology / Q000592:standards*
chemical_list: D004338:Drug Combinations; D058993:Oral Sprays; D010936:Plant Extracts; D002185:Cannabidiol; D013759:Dronabinol; C587251:nabiximols